ArticleDiscover oncology2026

Integrative network pharmacology and in vitro validation reveal the mechanisms by which Apigenin reverses MET-TKI resistance in non-small cell lung cancer.

Xiaofei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.